UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 84

Sortiert nach

Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy

PloS one, 2020-01, Vol.15 (1), p.e0228072-e0228072

2020

Volltextzugriff (PDF)

Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength

PloS one, 2021-03, Vol.16 (3), p.e0248721-e0248721

2021

Volltextzugriff (PDF)

Correction: Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy

PloS one, 2020-10, Vol.15 (10), p.e0241430-e0241430

2020

Volltextzugriff (PDF)

Best Trade-Off Point Method for Efficient Resource Provisioning in Spark

Algorithms, 2018-12, Vol.11 (12), p.190

Nghiem, Peter P.

2018

Volltextzugriff (PDF)

Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy

PloS one, 2020-10, Vol.15 (10), p.e0240317-e0240317

2020

Volltextzugriff (PDF)

Creation and characterization of an immortalized canine myoblast cell line: Myok9

Mammalian genome, 2020-04, Vol.31 (3-4), p.95-109

2020

Volltextzugriff (PDF)

Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy

Journal of the American Heart Association, 2019-08, Vol.8 (16), p.e012443-e012443

2019

Volltextzugriff (PDF)

OPN‐a induces muscle inflammation by increasing recruitment and activation of pro‐inflammatory macrophages

Experimental physiology, 2016-10, Vol.101 (10), p.1285-1300

2016

Volltextzugriff (PDF)

Gene therapies in canine models for Duchenne muscular dystrophy

Human genetics, 2019-05, Vol.138 (5), p.483-489

2019

Volltextzugriff (PDF)

A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20

Skeletal muscle, 2018-05, Vol.8 (1), p.16-16, Article 16

2018

Volltextzugriff (PDF)

Regulation of cellular anabolism by mTOR: or how I learned to stop worrying and love translation

Sports medicine and health science, 2020-12, Vol.2 (4), p.195-201

2020

Volltextzugriff (PDF)

Towards efficient resource provisioning in MapReduce

Journal of parallel and distributed computing, 2016-09, Vol.95, p.29-41

2016

Volltextzugriff (PDF)

Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models

Nature medicine, 2019-10, Vol.25 (10), p.1505-1511

2019

Volltextzugriff (PDF)

Correction to: Gene therapies in canine models for Duchenne muscular dystrophy

Human genetics, 2019-05, Vol.138 (5), p.491-491

2019

Volltextzugriff (PDF)

Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy

Science translational medicine, 2023-01, Vol.15 (677), p.eabo1815

2023

Volltextzugriff (PDF)

Whole genome sequencing reveals a 7 base-pair deletion in DMD exon 42 in a dog with muscular dystrophy

Mammalian genome, 2017-04, Vol.28 (3-4), p.106-113

2017

Volltextzugriff (PDF)

Sparing of the Dystrophin-Deficient Cranial Sartorius Muscle Is Associated with Classical and Novel Hypertrophy Pathways in GRMD Dogs

The American journal of pathology, 2013-11, Vol.183 (5), p.1411-1424

2013

Volltextzugriff (PDF)

Comprehensive assessment of physical activity correlated with muscle function in canine Duchenne muscular dystrophy

Annals of physical and rehabilitation medicine, 2022-09, Vol.65 (5), p.101611-101611, Article 101611

2022

Volltextzugriff (PDF)

Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells

Muscle & nerve, 2017-12, Vol.56 (6), p.1119-1127

2017

Volltextzugriff (PDF)

Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy

Molecular imaging and biology, 2018-10, Vol.20 (5), p.780-788

2018

Volltextzugriff (PDF)

Pharmacologic Management of Duchenne Muscular Dystrophy: Target Identification and Preclinical Trials

ILAR journal, 2014, Vol.55 (1), p.119-149

2014

Volltextzugriff (PDF)

Use of the six-minute walk test to characterize golden retriever muscular dystrophy

Neuromuscular disorders : NMD, 2016-12, Vol.26 (12), p.865-872

2016

Volltextzugriff (PDF)

Changes in Muscle Metabolism are Associated with Phenotypic Variability in Golden Retriever Muscular Dystrophy

The Yale journal of biology & medicine, 2017-09, Vol.90 (3), p.351-360

2017

Volltextzugriff (PDF)

Bioavailability of a novel midazolam gel after intranasal administration in dogs

American journal of veterinary research, 2012-04, Vol.73 (4), p.539-545

2012

Volltextzugriff (PDF)

Conventional and molecular diagnostic testing for the acute neurologic patient

Journal of veterinary emergency and critical care (San Antonio, Tex. : 2000), 2010-02, Vol.20 (1), p.46-61

2010

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(83)
Buchkapitel
(1)

Sprache

Englisch
(84)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy

Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength

Correction: Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy

Best Trade-Off Point Method for Efficient Resource Provisioning in Spark

Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy

Creation and characterization of an immortalized canine myoblast cell line: Myok9

Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy

OPN‐a induces muscle inflammation by increasing recruitment and activation of pro‐inflammatory macrophages

Gene therapies in canine models for Duchenne muscular dystrophy

A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20

Regulation of cellular anabolism by mTOR: or how I learned to stop worrying and love translation

Towards efficient resource provisioning in MapReduce

Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models

Correction to: Gene therapies in canine models for Duchenne muscular dystrophy

Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy

Whole genome sequencing reveals a 7 base-pair deletion in DMD exon 42 in a dog with muscular dystrophy

Sparing of the Dystrophin-Deficient Cranial Sartorius Muscle Is Associated with Classical and Novel Hypertrophy Pathways in GRMD Dogs

Comprehensive assessment of physical activity correlated with muscle function in canine Duchenne muscular dystrophy

Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells

Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy

Pharmacologic Management of Duchenne Muscular Dystrophy: Target Identification and Preclinical Trials

Use of the six-minute walk test to characterize golden retriever muscular dystrophy

Changes in Muscle Metabolism are Associated with Phenotypic Variability in Golden Retriever Muscular Dystrophy

Bioavailability of a novel midazolam gel after intranasal administration in dogs

Conventional and molecular diagnostic testing for the acute neurologic patient

Suchergebnisse filtern